New diabetes clinical trial: A Study to Evaluate the Efficacy of a Purified Native Type 1 Collagen Extracellular Matrix with Polyhexamethylene Biguanide Antimicrobial (PCMP) and Standard of Care Versus Standard of Care Alone in the Management of Nonhealing Diabetic Foot Ulcers

Published on: September 29, 2024 at 11:00PM
Conditions: Diabetic Foot Ulcer
Interventions: Other: Standard of Care; Device: PuraPly AM; Device: PuraPly XT
Sponsors: Organogenesis; Serena Group
Recruiting
https://ift.tt/jICtFR6